1. Home
  2. PGY vs MDXG Comparison

PGY vs MDXG Comparison

Compare PGY & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pagaya Technologies Ltd.

PGY

Pagaya Technologies Ltd.

HOLD

Current Price

$12.73

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

Logo MiMedx Group Inc

MDXG

MiMedx Group Inc

HOLD

Current Price

$3.61

Market Cap

530.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PGY
MDXG
Founded
2016
2006
Country
United States
United States
Employees
511
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
530.2M
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
PGY
MDXG
Price
$12.73
$3.61
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
6
Target Price
$34.50
$9.00
AVG Volume (30 Days)
3.5M
1.7M
Earning Date
05-07-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
14.29
EPS
N/A
N/A
Revenue
N/A
$418,630,000.00
Revenue This Year
$14.27
N/A
Revenue Next Year
$14.39
$13.02
P/E Ratio
$13.54
N/A
Revenue Growth
N/A
19.99
52 Week Low
$10.40
$3.03
52 Week High
$44.99
$7.99

Technical Indicators

Market Signals
Indicator
PGY
MDXG
Relative Strength Index (RSI) 43.68 49.42
Support Level $10.78 $3.45
Resistance Level $15.57 $7.39
Average True Range (ATR) 0.89 0.12
MACD -0.21 0.04
Stochastic Oscillator 12.12 51.43

Price Performance

Historical Comparison
PGY
MDXG

About PGY Pagaya Technologies Ltd.

Pagaya Technologies Ltd is a product-focused technology company. It uses machine learning, a vast data network, and an AI-driven approach to offer comprehensive consumer credit and residential real estate products for its partners, their customers, and investors. Its suite of products includes Decline Monetization, Dual Look, First Look, Affiliate Optimizer Engine, Direct Marketing Engine, and FastPass, providing lenders with an AI-powered credit and acquisition ecosystem that helps them approve more borrowers, capture more demand, and grow without adding risk. Geographically, the company generates maximum revenue from its business in the United States.

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Share on Social Networks: